参考文献/References:
[1]王爱荷,刘书贤,杜艳青,等.老年高血压患者24小时动态血压监测参数及节律与早期肾损害的关系[J].中国医师进修杂志,2017,40(2):153-156,157.[2]杨旦红,吴菁,葛莹,等.高血压患者24h动态血压、随访血压与诊室血压测量结果比较[J].中国全科医学,2019,3(21):278-280.[3]李瑶,姚思宇,石亚君,等.高血压合并冠心病患者血压负荷与冠脉病变严重程度的关系研究[J].中国分子心脏病学杂志,2017,17(4):2144-2146.[4]应佐华,杨良瑞,高琴.硝苯地平缓释片与控释片治疗60岁以上原发性高血压患者疗效比较[J].实用临床医药杂志,2018,22(17):99-101.[5]李茜娴.硝苯地平缓释片与控释片治疗妊娠期高血压疗效对比探讨[J].现代诊断与治疗,2019,30(10):1625-1627.[6]丁燕.硝苯地平缓释片与硝苯地平控释片治疗高血压的疗效比较[J].中国药物经济学,2014(8):48-49.[7]王磊,魏新伟,于芳. 不同降压药物联合治疗对老年高血压患者血压变异性的影响[J]. 天津医药,2016,44(1):105-109.[8]魏强.高血压治疗中采用不同剂型硝苯地平的效果对比[J].临床检验杂志,2017,6(2):336-337.[9]虞春宜.偶测血压与24h动态血压监测对妊娠期高血压疾病诊断价值比较[J].蚌埠医学院学报,2017,15(1):68-70.[10]吕红华.硝苯地平控释片与硝苯地平缓释片治疗高血压效果观察[J].临床医学,2019,39(3):118-120.[11]郑晓玲,翟炜.硝苯地平缓释片与硝苯地平控释片治疗原发性高血压的疗效比较[J].临床医学,2020,40(11):97-98.[12]吴盛忠,刘长鑫,赵明星,等.动态心电图和动态血压同步监测在原发性高血压患者中的应用[J].基层医学论坛,2017,21(19):2590-2591.[13]李建敏,李晨,寿松涛.24h动态血压监测在原发性高血压患者心血管危险分层评估中的价值[J].山东医药,2017,17(24):68-70.[14]陈河清,王振清.原发性高血压患者血脂水平与血压变异性的相关分析[J].中国处方药,2018,16(5):121-122.[15]应佐华,杨良瑞,高琴.硝苯地平缓释片与控释片治疗60岁以上原发性高血压患者疗效比较[J].实用临床医药杂志,2018,9(8):75-77.[16]张波,纪大鹏.24h动态血压监测对原发性高血压患者心脑血管风险评估的价值[J].现代仪器与医疗,2018,24(2):45-46.[17]杨健.硝苯地平控释片对老年原发性高血压患者临床疗效及心率的影响[J].中国处方药,2019,17(5):69-70.[18]崔锦娜,姚远.24h动态血压监测在老年高血压患者中的应用[J].心血管康复医学杂志,2018,28(2):90-92.[19]陈登.动态血压监测对高血压诊治的临床价值分析[J].中西医结合心血管病电子杂志,2017,5(35):46.[20]潘远安,刘江红,张志超,等.硝苯地平缓释片与硝苯地平控释片治疗高血压合并糖尿病的疗效比较[J]现代诊断与治疗,2017,28(7):1225-1227.
相似文献/References:
[1]陈 萍,陈 磊.硝苯地平联合硫酸镁治疗重度妊娠高血压的临床效果分析[J].医学信息,2018,31(04):109.[doi:10.3969/j.issn.1006-1959.2018.04.037]
CHEN Ping,CHEN Lei.Clinical Analysis of Nifedipine Combined with Magnesium Sulfate in Treating Severe Pregnancy Induced Hypertension[J].Medical Information,2018,31(10):109.[doi:10.3969/j.issn.1006-1959.2018.04.037]
[2]段淑婷,王义围,王兆鹏.高血压病合并糖调节受损患者血压变异性的相关研究[J].医学信息,2018,31(05):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
DUAN Shu-ting,WANG Yi-wei,WANG Zhao-peng.Study on Blood Pressure Variability in Patients with Hypertension Complicated with Impaired Glucose Regulation[J].Medical Information,2018,31(10):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
[3]孙洪艳.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效观察[J].医学信息,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.10.043]
SUN Hong-yan.Efficacy of Nifedipine Combined with Irbesartan in the Treatment of Diabetes Complicated with Hypertension[J].Medical Information,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.10.043]
[4]李信明,刘春梅,任正强,等.供需平衡视角下原发性高血压的病机与防治[J].医学信息,2018,31(19):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
LI Xin-Ming,LIU Chun-Mei,REN Zheng-Qiang,et al.Pathogenesis and Prevention of Essential Hypertension from the Perspective of Supply and Demand Balance[J].Medical Information,2018,31(10):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
[5]穆大明.厄贝沙坦氢氯噻嗪与福辛普利治疗原发性高血压的疗效观察[J].医学信息,2019,32(03):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
MU Da-ming.Efficacy of Irbesartan Hydrochlorothiazide and Fosinopril in the Treatment of Essential Hypertension[J].Medical Information,2019,32(10):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
[6]熊依良.奥美沙坦酯氢氯噻嗪片治疗轻中度原发性高血压的疗效及安全性分析[J].医学信息,2018,31(19):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
XIONG Yi-liang.Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Tablets in the Treatment of Mild to Moderate Essential Hypertension[J].Medical Information,2018,31(10):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
[7]郑艳芳,郭军霞,张永春.原发性高血压合并阵发性心房颤动的危险因素分析[J].医学信息,2021,34(22):51.[doi:10.3969/j.issn.1006-1959.2021.22.014]
ZHENG Yan-fang,GUO Jun-xia,ZHANG Yong-chun.Risk Factors Analysis of Essential Hypertension Complicated with Paroxysmal Atrial Fibrillation[J].Medical Information,2021,34(10):51.[doi:10.3969/j.issn.1006-1959.2021.22.014]
[8]潘建鑫.高血压患者血小板/淋巴细胞比值与颈动脉粥样硬化的相关性分析[J].医学信息,2020,33(05):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
Pan Jianxin.Correlation analysis of platelet/lymphocyte ratio and carotid atherosclerosisin patients with primary hypertension[J].Medical Information,2020,33(10):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
[9]李文超.硝苯地平联合阿司匹林对妊娠期高血压患者母婴结局的影响[J].医学信息,2020,33(05):151.[doi:10.3969/j.issn.1006-1959.2020.05.049]
LI Wen-chao.Effects of Nifedipine Combined with Aspirin on Maternal and Infant Outcomes in Patients with Gestational Hypertension[J].Medical Information,2020,33(10):151.[doi:10.3969/j.issn.1006-1959.2020.05.049]
[10]谢祥红.AngⅡ、ET-1对高血压患者病情发生发展的影响[J].医学信息,2020,33(16):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]
XIE Xiang-hong.Effects of AngⅡ and ET-1 on the Occurrence and Development of Hypertension Patients[J].Medical Information,2020,33(10):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]